(Q44323645)

2 December 2017

Tissue microarray based analysis of prognostic markers in invasive bladder cancer: much effort to no avail? (English)

1 reference

2 December 2017

1 reference

5

1 reference

2 December 2017

Fredrik Liedberg

1

1 reference

2 December 2017

Harald Anderson

2

1 reference

2 December 2017

Gunilla Chebil

3

1 reference

2 December 2017

Sigurdur Gudjonsson

4

1 reference

2 December 2017

David Lindgren

6

1 reference

2 December 2017

Lena-Maria Lundberg

7

1 reference

2 December 2017

Kristina Lövgren

8

1 reference

2 December 2017

Mårten Fernö

9

1 reference

2 December 2017

Wiking Månsson

10

1 reference

2 December 2017

22 October 2007

1 reference

2 December 2017

1 reference

2 December 2017

26

1 reference

2 December 2017

17-24

1 reference

2 December 2017

1

1 reference

2 December 2017

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Molecular staging of bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Prospective Evaluation of Ki–67 Labeling in Predicting the Recurrence and Progression of Superficial Bladder Transitional Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor rece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Expression of E-Cadherin and α-, β-, γ-Catenins in Patients With Bladder Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

erbB receptor expression patterns in human bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Prognostic Values of p53 and HER-2/neu Coexpression in Invasive Bladder Cancer in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Tissue microarrays and their relevance to the urologist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Tissue microarray sampling strategy for prostate cancer biomarker analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

HER-2 and TOP2A coamplification in urinary bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.08.021

10.1016/J.UROLONC.2006.08.021

7 January 2021

Identifiers

DOI

1 reference

release_xuxyalnebncivhydelxxh2p5wy

2 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xuxyalnebncivhydelxxh2p5wy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference